silver diammine fluoride

Small moleculeexperimental

Silver diammine fluoride (SDF), also known as silver diamine fluoride in most of the dental literature, is a topical medication used to treat and prevent dental caries and relieve dentinal hypersensitivity. It is a colorless or blue-tinted, odourless liquid composed of silver, ammonium and fluoride ions at a pH of 10.4 or 13. Ammonia compounds reduce the oxidative potential of SDF, increase its stability and helps to maintain a constant concentration over a period of time, rendering it safe for use in the mouth. Silver and fluoride ions possess antimicrobial properties and are used in the remineralization of enamel and dentin on teeth for preventing and arresting dental caries. — Wikipedia

Clinical trial activity

59 trials · 40 clinical orgs · 0 marketing orgs

Phase 1
7
Phase 2
16
Phase 3
17
Phase 4
11

Earliest trial started Jan 1, 2012 (NCT02360124)

Timeline

2010s

  1. Jan 1, 2012

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2013

    Earliest Phase 3 Sponsor(trial)

  3. Jan 1, 2016

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Loading structure…

SMILES

N.N.[Ag+].[F-]
Mol. weight
160.93 g/mol
Chirality
Achiral Molecule
Inorganic
Yes
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • diamminefluorosilver
  • diammine silver fluoride
  • sdf
  • silver ammonia fluoride
  • silver diamine fluoride
  • silver diamine fluoride
  • silver diamine fluoride
  • silver diammine fluoride
  • silver fluoride

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07194629Phase 4Oct 1, 2025University of Montreal
NCT07181967N/ASep 15, 2025Assiut University
NCT06797882Phase 2Jan 31, 2025National University of Malaysia
NCT06489093Early Phase 1 (Phase 1)Jul 29, 2024Plovdiv Medical University
NCT06241261Phase 2Jan 1, 2024The University of Hong Kong
NCT06699199Phase 4Nov 1, 2023King Abdul-Aziz University
NCT05941429Phase 1Aug 31, 2023Cairo University
NCT06316323Phase 1Feb 1, 2023Universiti Teknologi Mara
NCT05655286N/AJan 1, 2023The University of Hong Kong
NCT06293547N/AAug 10, 2022Cumhuriyet University
NCT05425368N/AAug 1, 2022Cairo University
NCT05337449N/AJul 15, 2022Cairo University
NCT05249231N/AApr 30, 2022Cairo University
NCT05255913N/AMar 31, 2022Alexandria University
NCT05761041Phase 3Mar 28, 2022Alexandria University
NCT05221749Phase 3Mar 15, 2022Alexandria University
NCT05485272N/AFeb 1, 2022Cairo University
NCT05188846Phase 3Jan 25, 2022Cairo University
NCT05772039Phase 4Jan 18, 2022SDI Limited, Univerisiti Sains Malaysia
NCT04889196Phase 3Sep 1, 2021Cairo University
Showing 20 of 59 trials
Page 1 / 3

Organizations

Research & Development (40)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Cairo UniversityAcademic/Hospital151542017
The University of Hong KongAcademic/Hospital9932012
Alexandria UniversityAcademic/Hospital7732018
Mansoura UniversityAcademic/Hospital3322019
University of IowaAcademic/Hospital2122016
Advantage DentalAcademic/Hospital1112016
Advantage Silver Dental Arrest, LLCFor profit1112019
Ain Shams UniversityAcademic/Hospital1112019
Al Azhar UniversityAcademic/Hospital1112019
Assiut UniversityAcademic/Hospital1112025
Beaty DentFor profit1112021
British University In EgyptAcademic/Hospital1112020
Cumhuriyet UniversityAcademic/Hospital1112022
Federal University of Rio de JaneiroAcademic/Hospital1112016
Fluminense Federal UniversityAcademic/Hospital1012016
Fundação de Amparo à Pesquisa do Estado de São PauloAcademic/Hospital1012014
Jordan UniversityAcademic/Hospital1012019
King Abdul-Aziz UniversityAcademic/Hospital1112023
King Abdullah Medical CityAcademic/Hospital1112019
Kuwait UniversityAcademic/Hospital1112015
40 organizations
Page 1 / 2